Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-26179516

ABSTRACT

The discovery of fatty acid esters of monochloropropanediol (MCPD) and glycidol generated during the refinement process in vegetable fats and oils caused concerns about possible adverse health effects. As these fats are components of infant formula, the current investigation of the MCPD and glycidyl ester contents in infant formula was necessary to update the data for risk assessment purposes. For the analysis of 3-MCPD, 2-MCPD and glycidyl esters in infant formula, an existing method for fats and oils had to be modified and validated. The fat fraction containing MCPD and glycidyl esters was extracted from infant formula by accelerated solvent extraction (ASE). The extracted fat was then analysed according to an established method for fats and oils. Glycidyl esters are converted to monobrompropanediol (3-MBPD) esters, MCPD and 3-MBPD esters hydrolysed subsequently and after derivatisation detected by GC-MS. Seven different products of infant formula, covering two types and five lots each, altogether 70 samples, were bought in retail markets and analysed. In all samples, 3-MCPD and glycidyl esters could be detected. Both 3-MCPD and glycidyl esters' concentration levels were found to be lower in comparison with earlier investigations described in the literature. The occurrence of 2-MCPD esters in infant formula was investigated for the first time and revealed concentrations about half of 3-MCPD ester concentrations.


Subject(s)
Epoxy Compounds/chemistry , Esters/analysis , Fatty Acids/analysis , Food Contamination/analysis , Glycerol/analogs & derivatives , Infant Formula/chemistry , Propanols/chemistry , Epoxy Compounds/analysis , Esters/chemistry , Fatty Acids/chemistry , Glycerol/analysis , Glycerol/chemistry , Humans , Infant , Infant, Newborn , Propanols/analysis
2.
Mol Nutr Food Res ; 55(4): 644-53, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21462332

ABSTRACT

SCOPE: Cassia cinnamon contains high levels (up to 1 %) of coumarin. Heavy consumption of this spice may result in a dose exceeding the tolerable daily intake (TDI). In this context, the question was raised whether coumarin in the plant matrix of cinnamon has the same bioavailability as isolated coumarin. METHODS AND RESULTS: A four-way crossover study was performed, in which the same dose of 12 mg coumarin was administered in different formulations to 24 healthy volunteers. The relative extent of absorption measured as urinary excretion of the main metabolite 7-hydroxycoumarin (7OHC) was found to be 62.8% for isolated coumarin in a capsule (reference), 56.0% for cinnamon in capsules, 66.1% for cinnamon tea, and 54.7% for cinnamon in rice pudding (means, n=23, observation period 8 hours). Additionally, 7OHC plasma levels were measured for 105 minutes after administration and revealed a fast absorption of coumarin from cinnamon tea leading to the highest peak concentrations. CONCLUSION: The relative extent of absorption of coumarin from powder of cassia cinnamon is only slightly lower than that of isolated coumarin. Therefore, the TDI of coumarin can be used for risk assessment of coumarin exposure from cinnamon-containing meals.


Subject(s)
Beverages , Cinnamomum aromaticum/chemistry , Coumarins/metabolism , Food , Plant Bark/chemistry , Adult , Beverages/adverse effects , Capsules , Coumarins/adverse effects , Cross-Over Studies , Female , Food/adverse effects , Glucuronides/blood , Glucuronides/urine , Humans , Intestinal Absorption , Kinetics , Male , Middle Aged , Powders , Risk Assessment/methods , Spices/adverse effects , Umbelliferones/blood , Umbelliferones/chemistry , Umbelliferones/urine
3.
Mol Nutr Food Res ; 54(2): 228-39, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20024932

ABSTRACT

Coumarin is a secondary phytochemical with hepatotoxic and carcinogenic properties. For the carcinogenic effect, a genotoxic mechanism was considered possible, but was discounted by the European Food Safety Authority in 2004 based on new evidence. This allowed the derivation of a tolerable daily intake (TDI) for the first time, and a value of 0.1 mg/kg body weight was arrived at based on animal hepatotoxicity data. However, clinical data on hepatotoxicity from patients treated with coumarin as medicinal drug is also available. This data revealed a subgroup of the human population being more susceptible for the hepatotoxic effect than the animal species investigated. The cause of the high susceptibility is currently unknown; possible mechanisms are discussed. Using the human data, a TDI of 0.1 mg/kg body weight was derived, confirming that of the European Food Safety Authority. Nutritional exposure may be considerably, and is mainly due to use of cassia cinnamon, which is a popular spice especially, used for cookies and sweet dishes. To estimate exposure to coumarin during the Christmas season in Germany, a telephone survey was performed with more than 1000 randomly selected persons. Heavy consumers of cassia cinnamon may reach a daily coumarin intake corresponding to the TDI.


Subject(s)
Coumarins/toxicity , Flavoring Agents/toxicity , Animals , Biotransformation/genetics , Chemical and Drug Induced Liver Injury , Coumarins/standards , Coumarins/therapeutic use , Edema/drug therapy , Flavoring Agents/administration & dosage , Flavoring Agents/standards , Humans , Liver Neoplasms/chemically induced , Lymphedema/drug therapy , Plants, Medicinal/chemistry , Risk Assessment , Species Specificity , Toxicity Tests , Venous Insufficiency/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...